CXCR3 in T cell function
- PMID: 21376175
- PMCID: PMC3065205
- DOI: 10.1016/j.yexcr.2010.12.017
CXCR3 in T cell function
Abstract
CXCR3 is a chemokine receptor that is highly expressed on effector T cells and plays an important role in T cell trafficking and function. CXCR3 is rapidly induced on naïve cells following activation and preferentially remains highly expressed on Th1-type CD4(+) T cells and effector CD8(+) T cells. CXCR3 is activated by three interferon-inducible ligands CXCL9 (MIG), CXCL10 (IP-10) and CXCL11 (I-TAC). Early studies demonstrated a role for CXCR3 in the trafficking of Th1 and CD8 T cells to peripheral sites of Th1-type inflammation and the establishment of a Th1 amplification loop mediated by IFNγ and the IFNγ-inducible CXCR3 ligands. More recent studies have also suggested that CXCR3 plays a role in the migration of T cells in the microenvironment of the peripheral tissue and lymphoid compartment, facilitating the interaction of T cells with antigen presenting cells leading to the generation of effector and memory cells.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures

Initial innate challenge, such as bacterial or viral infection, activates TLRs and RNA helicases leading to the release of IFNα/β and subsequent secretion of chemokines, predominantly CXCL10.
CXCL10 recruits CD4+ Th1 cells and possibly NK cells into the target tissue.
DCs in the tissue present antigen to CD4+ Th1 cells, which in turn secrete IFNγ.
Tissue resident DCs and other cells take up IFNγ leading to secretion of CXCL9 and CXCL10.
CXCL9 and CXCL10 recruit CD8+ CTLs into the tissue
Migrated CD8+ CTLs secrete IFNγ, further stimulating tissue resident cells to produce more CXCL9 and CXCL10.
Increased chemokine release amplifies inflammation, leading to further recruitment of CXCR3-expressing Th1 T cells and CTLs.
Increased inflammation can also attract in CTLs in a CXCR3-independent manner.
CXCR3-expressing CD4+ Treg cells may also enter the tissue, to counterbalance the CTL and Th1 cell response and lead to resolution of Th1 inflammation.
References
-
- Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol. 2008;9:970–980. - PubMed
-
- Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD. Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J Immunol. 2006;177:6991–6998. - PubMed
-
- Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998;187:2009–2021. - PMC - PubMed
-
- Loetscher M, Loetscher P, Brass N, Meese E, Moser B. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur J Immunol. 1998;28:3696–3705. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials